(Total Views: 749)
Posted On: 08/13/2020 8:57:54 PM
Post# of 148908
https://www.bioworld.com/articles/496648-regu...-4-10-2020
Announced it will submit requests for pre-submission meetings in the U.K. for leronlimab as an HIV treatment in combination with HAART for highly treatment-experienced HIV patients, as well as for emergency approval for COVID-19 patients with mild to moderate symptoms
Announced it will submit requests for pre-submission meetings in the U.K. for leronlimab as an HIV treatment in combination with HAART for highly treatment-experienced HIV patients, as well as for emergency approval for COVID-19 patients with mild to moderate symptoms
(3)
(0)Scroll down for more posts ▼
